MAP3K20 and ovarian carcinoma: In this study, our data also showed that knockdown of MLK7-AS1 upregulated epithelial maker expression levels but downregulated the expression levels of mesenchymal marker genes both in in vitro and vivo, while the suppression effects were partly reversed by miR-375-inhibition, indicating MLK7-AS1 might interact with miR-375 to promote cell proliferation via the EMT pathway in ovarian cancer cells.